Clinical Trial Update: WEUSKOP5410: Observational Study in ENABLE Clinical Trials

View source ↗

Summary

This is a completed observational study (WEUSKOP5410) within ENABLE Clinical Trials sponsored by GlaxoSmithKline, focusing on Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C | Status: COMPLETED